Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 7;21(10):126.
doi: 10.1007/s11886-019-1211-z.

Is There a Safety Concern for Drug-Coated Balloons in Peripheral Arterial Disease?

Mohamed M Gad  1   2 , Antonette K Karrthik  1 , Ahmad A Mahmoud  3 , Ahmed N Mahmoud  4
Affiliations
Review

Is There a Safety Concern for Drug-Coated Balloons in Peripheral Arterial Disease?

Mohamed M Gad et al. Curr Cardiol Rep. .

Abstract

Purpose of review: Drug-coated balloons (DEB) and drug-eluting stents (DES) emerged as a tool to aid in lowering the rates of neointimal hyperplasia and target lesion restenosis following endovascular peripheral arterial disease (PAD) interventions.

Recent findings: Although the initial trials comparing these devices with non-drug balloons and stents showed favorable results, more recent data raised concerns regarding the mid to long-term safety of these devices. In this review, we will discuss the evolution of endovascular therapy for PAD, with highlights regarding the recent debates on the long-term safety of the drug-coated devices for treatment of PAD.

Keywords: Endovascular therapy; Mortality; Paclitaxel; Peripheral arterial disease.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. J Vasc Interv Radiol. 2001 Jan;12(1):23-31 - PubMed
    1. J Vasc Interv Radiol. 2001 Aug;12(8):935-42 - PubMed
    1. Radiology. 2002 Jan;222(1):37-43 - PubMed
    1. J Vasc Surg. 2003 Mar;37(3):487-94 - PubMed
    1. Radiology. 2004 Aug;232(2):516-21 - PubMed

MeSH terms

LinkOut - more resources